Abstract
Abstract
Introduction
Phenobarbital is a commonly used anticonvulsant for the treatment of canine epileptic seizures. In addition to its central nervous system (CNS) depressing effects, long-term phenobarbital administration affects liver function. However, broader metabolic consequences of phenobarbital treatment are poorly characterized.
Objectives
To identify metabolic changes in the sera of phenobarbital-treated dogs and to investigate the relationship between serum phenobarbital concentration and metabolite levels.
Methods
Leftovers of clinical samples were used: 58 cases with phenobarbital concentrations ranging from 7.8 µg/mL to 50.8 µg/mL, and 25 controls. The study design was cross-sectional. The samples were analyzed by a canine-specific 1H NMR metabolomics platform. Differences between the case and control groups were evaluated by logistic regression. The linear relationship between metabolite and phenobarbital concentrations was evaluated using linear regression.
Results
Increasing concentrations of glycoprotein acetyls, LDL particle size, palmitic acid, and saturated fatty acids, and decreasing concentrations of albumin, glutamine, histidine, LDL particle concentration, multiple HDL measures, and polyunsaturated fatty acids increased the odds of the sample belonging to the phenobarbital-treated group, having a p-value < .0033, and area under the curve (AUC) > .7. Albumin and glycoprotein acetyls had the best discriminative ability between the groups (AUC: .94). No linear associations between phenobarbital and metabolite concentrations were observed.
Conclusion
The identified metabolites are known to associate with, for example, liver and CNS function, inflammatory processes and drug binding. The lack of a linear association to phenobarbital concentration suggests that other factors than the blood phenobarbital concentration contribute to the magnitude of metabolic changes.
Funder
PetBIOMICS Ltd
University of Helsinki including Helsinki University Central Hospital
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference41 articles.
1. Al Khayat, H. A., Awadalla, M. M., Al Wakad, A., & Marzook, Z. A. (2010). Polyunsaturated fatty acids in children with idiopathic intractable epilepsy: Serum levels and therapeutic response. Journal of Pediatric Neurology, 8, 175–185. https://doi.org/10.3233/JPN-2010-0398
2. Bhowmik, M., Khanam, R., & Vohora, D. (2012). Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: A systemic consideration of recent progress and perspectives. British Journal of Pharmacology, 167(7), 1398–1414. https://doi.org/10.1111/j.1476-5381.2012.02093.x
3. Chauvet, A. E., Feldman, E. C., & Kass, P. H. (1995). Effects of phenobarbital administration on results of serum biochemical analyses and adrenocortical function tests in epileptic dogs. Journal of the American Veterinary Medical Association, 207(10), 1305–1307. https://www.ncbi.nlm.nih.gov/pubmed/7591923
4. Chen, Z., Li, W.-D., Zhu, L.-J., Shen, Y.-J., & Wei, E.-Q. (2002). Effects of histidine, a precursor of histamine, on pentylenetetrazole-induced seizures in rats. Acta Pharmacologica Sinica, 23(4), 361–366.
5. Chen, Z., Sugimoto, Y., & Kamei, C. (1999). Effects of Intracerebroventricular Injection of α-Fluoromethylhistidine on Radial Maze Performance in Rats. Pharmacology Biochemistry and Behavior, 64(3), 513–518. https://doi.org/10.1016/S0091-3057(99)00128-8
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献